Retina is a Marker for Cerebrovascular Heath — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Retina is a Marker for Cerebrovascular Heath — Stella

Home/Cerebral Small Vessel Diseases/

View on ClinicalTrials.gov

Recruiting

Back to Cerebral Small Vessel Diseases trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Mayo Clinic Florida, Jacksonville, Florida

Key details

Phase

Early testing / Safety & dosing

Sponsor

Mayo Clinic

Enrollment target

~100 participants

Started

February 2021

Primary completion

June 2026

Age range

18 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.